264 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
pleased to report another quarter of strong financial results and we are now actively executing on our investment strategy as evidenced by the recent
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
pleased to report another quarter of strong financial results and we are now actively executing on our investment strategy as evidenced by the recent
8-K
EX-99.1
ladsns5o2 qqv66jux0
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm
S-3ASR
o9dw109akgbv7mvc3vo
30 Sep 22
Automatic shelf registration
4:17pm
8-K
EX-99.1
l5ugocuc
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
nqq5m
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
2d3 3un6fxyjk52s2
21 Jun 22
Regulation FD Disclosure
6:19am
425
ia9qqd72g2eigjsxi20
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
tqocopybi2gp3kp7027t
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
dwwrrzlv982ue 4ztmf4
24 Mar 22
Business combination disclosure
9:09am
8-K
pi39jy
24 Mar 22
Entry into a Material Definitive Agreement
9:08am